查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195538

3D 腹腔鏡成像市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

3D Laparoscopy Imaging Market- Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 3D 腹腔鏡成像市場在預測期內（2022 年至 2027 年）將以近 4.5% 的複合年增長率增長。

COVID-19 的爆發使 3D 腹腔鏡手術重新成為人們關注的焦點，因為研究表明接受減肥手術的患者入院和重症監護病房 (ICU) 的風險較低 根據 2021 年 1 月發表在《肥胖及相關疾病外科》雜誌上的“既往代謝和減肥手術與肥胖患者冠狀病毒病 (COVID-19) 的嚴重程度的關聯”研究，克利夫蘭診所的研究作者委託進行的一項研究發現有代謝手術史的嚴重肥胖患者感染 SARS-CoV-2 的嚴重程度較輕，住院和入住 ICU 的風險較低，這導致了上述觀察結果。沒錯。 預計這將增加對減肥手術的需求，進而對 3D 腹腔鏡設備的需求產生積極影響。 此外，根據 Bhavid-19 的一項名為“COVID-19 大流行期間的腹腔鏡胃腸手術”的研究，這是一項“單中心經驗”。 Bhavin Patel 的“單中心體驗” 2021 年 4 月 由於 COVID-19 時代，腹腔鏡手術正在減少，由於病毒感染的風險，腹腔鏡手術成為高風險手術。 因此，腹腔鏡手術的下降可能會阻礙腹腔鏡影像市場。 因此，市場在 COVID-19 時代受到了嚴重影響。

市場增長因素包括對 3D 成像技術的日益偏好和進步、肥胖的增加和對減肥手術的需求增加，以及對微創手術的需求增加。

是否應該將診所從 2D 環境替換為 3D 環境，以便對腹腔鏡新手進行有效培訓？ A Critical Analysis of the Learning Curve for Basic Skills”（2022 年 1 月，Frontier in Surgery），一項簡單的標準化測試表明，腹腔鏡新手在 2D 和 3D 技術之間經歷了顯著的執行時間和錯誤率。據說存在差異。 因此，外科醫生可能會繼續接受這兩種技術的培訓。 因此，外科醫生越來越多地採用 3D 技術有望推動市場增長。

此外，由於肥胖患病率上升和對減肥手術的需求，市場正在增長。 根據世界衛生組織 2021 年 6 月的數據，2020 年有 3900 萬五歲以下兒童超重或肥胖。 超重和肥胖曾經被認為只是高收入國家的問題，現在在低收入和中等收入國家變得越來越普遍，尤其是在城市地區。 根據世界肥胖聯盟發布的 2022 年 3 月世界肥胖地圖集，到 2030 年，全球將有 10 億人肥胖，其中包括五分之一的女性和七分之一的男性。我預測。 因此，由於肥胖患病率上升和治療需求增加，預計 3D 腹腔鏡成像市場將在預測期內增長。

此外，傳統的腹腔鏡攝像機僅包含二維 (2D) 系統，雖然高清 (HD) 系統可以改善圖形，但它們缺乏深度感知和空間感知。 通過克服立體視覺的喪失，3D 系統可以改進腹腔鏡訓練，這可能對市場增長產生積極影響。 例如，2020 年 1 月，Karl Storz SE & Co.KG 推出了帶有模塊化相機平台的新型 3D 手術成像系統。 這個新系統可以更好地可視化不同手術區域的顯微手術和開放式乾預。

因此，上述所有因素都有望在預測期內推動市場增長。 然而，與產品相關的高成本限制了市場增長。

3D腹腔鏡成像市場趨勢

預計在預測期內，減肥手術將佔據重要的應用市場份額

隨著減肥手術數量的增加，市場有望繼續增長。 3D 腹腔鏡成像系統的適用性將在減肥手術中得到擴展，因為外科醫生需要在手術前對解剖結構進行立體觀察以進行準確的解剖。

根據世界衛生組織 2021 年 6 月發布的一份報告，據說世界上五分之一的兒童和青少年超重。 在過去的幾十年裡，肥胖的發病率急劇上升，現在被認為是一種全球流行病，尤其是在發達國家，那裡的生活方式疾病如焦慮、壓力、吸煙和飲酒很普遍。我有。 此外，“印度的減肥和代謝手術：我們的立場是什麼？ 此外，同樣的數據表明，全世界有超過 19 億成年人超重，6.5 億人肥胖。 因此，肥胖的高負擔和全球減肥手術數量的增加預計將推動對 3D 腹腔鏡圖像的需求，從而促進該領域的增長。

肥胖還與過早死亡率顯著增加、生活質量差和醫療費用高昂有關。 常見的合併症包括高血壓、2 型糖尿病、血脂異常、心肌梗塞、某些癌症、中風、睡眠呼吸暫停和骨關節炎。 許多合併症也是導致死亡的主要原因。

因此，提高減肥手術技術的安全性將推動該細分市場的增長。

北美在市場上佔據主導地位，預計在預測期內將繼續如此。

在預測期內，北美主導著 3D 腹腔鏡成像市場。 這是由於越來越多的人傾向於腹腔鏡手術而不是開腹手術，以及人們越來越意識到微創手術的好處。 此外，主要參與者之間的產品創新競爭也會影響市場。

此外，對微創 3D 腹腔鏡設備不斷增長的需求正在推動市場發展。 微創手術方法因其創傷小而被廣泛使用。 例如，2020 年 12 月，奧林巴斯宣佈為其用於微創手術的 VISERA ELITE II 手術成像平台增加 3D 和紅外功能。 添加這樣的平台可以幫助醫院和運營中心提高效率並降低成本。 應用於婦科、普通外科、骨科、泌尿外科、耳鼻喉科等各個領域。 此外，一些國家的健康保險公司支付微創腹腔鏡手術費用。 根據 2022 年 3 月的 Medicare Benefits Schedule，高達 75% 的腹腔鏡手術現在由 Medicare (MBS) 承保。 因此，患者對微創手術的偏好正在增加。

此外，該地區的肥胖流行病有望提振市場。 2020 年 9 月 美國疾病控制與預防中心 (CDC) 2022 年 5 月 美國的肥胖患病率已從 30.5% 上升至 41.9%。 嚴重肥胖的患病率從 4.7% 上升到 9.2%。 此外，根據 2021 年 6 月發布的美國國家健康統計報告，在 20 歲及以上的成年人中，肥胖患病率為 41.9%，嚴重肥胖為 9.2%，糖尿病為 14.8%。 預計人口中肥胖患病率的增加將推動美國的減肥手術市場。 因此，肥胖患病率的增加和治療費用的增加預計將推動市場增長。

預計主要市場參與者推出技術先進的產品將在預測期內推動市場增長。 2020 年 12 月，奧林巴斯公司發布了其剛性 3D ENDOEYE 視頻腹腔鏡的升級版，與傳統的 3D 腹腔鏡相比，它為外科醫生提供了更好的控制。 這一升級為外科醫生提供了真正的水平方向。

因此，減肥和泌尿外科手術對 3D 腹腔鏡成像的需求不斷增長，預計將推動該地區的市場增長。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對 3D 成像技術的偏好和進步
    • 肥胖症的增加和對減肥手術的需求
    • 對微創手術的需求不斷增長
  • 市場製約因素
    • 與產品相關的高成本
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 通過申請
    • 婦科手術
    • 減肥手術
    • 泌尿外科
    • 其他應用
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Olympus Corporation
    • Sometech Inc.
    • Karl Storz SE & Co. KG
    • B. Braun Melsungen AG
    • Conmed Corporation
    • Medtronic Plc
    • Siemens Healthineers
    • Stryker Corporation
    • Johnson & Johnson Medical Devices
    • Richard Wolf GmbH
    • Xion Medical
    • Pentax Medical
    • Fujifilm Healthcare

第7章 市場機會今後動向

簡介目錄
Product Code: 67242

The 3D laparoscopy imaging market is expected to register a CAGR of nearly 4.5% over the forecast period (2022-2027).

With the outbreak of COVID-19, 3D laparoscopy procedures have seen renewed focus as studies have shown that patients who had undergone bariatric surgeries had a lower risk of hospital and intensive care unit (ICU) admissions. According to the study titled "Association of prior metabolic and bariatric surgery with the severity of coronavirus disease (COVID-19) in patients with obesity" published in the Surgery for Obesity and Related Diseases in January 2021, researchers at the Cleveland Clinic commissioned a study and they came up with the above observation that patients with severe obesity who have histories of metabolic surgery have SARS-CoV-2 infections that are less severe, as shown by lower risks of hospital and ICU admission. This is likely to increase the demand for bariatric procedures, which will eventually positively affect the demand for 3D laparoscopy devices. Moreover, according to the study titled "Laparoscopic Gastrointestinal Surgery During COVID-19 Pandemic: Single-Center Experience" by Bhavin Patel in April 2021, laparoscopic procedures have decreased as a result of the COVID-19 era, making it a risky procedure due to a potential risk of viral transmission. Therefore, a decline in laparoscopic surgery could hinder the laparoscopy imaging market. Consequently, the market was significantly impacted during COVID-19.

The factors driving market growth include increasing preference for and advancements in 3D imaging technology, increase in obesity and rising demand for bariatric surgeries, and rising demand for minimally invasive procedures.

According to the study titled "Must Clinics Replace 2D by 3D Environments for an Efficient Training of Laparoscopic Novices? A Critical Analysis of the Learning Curve for Basic Skills" published in the Frontier in Surgery in January 2022, in a straightforward standardized test, laparoscopic novices showed a significant difference between 2D and 3D technology in performance time and error rate. Thus, surgeons may continue to receive training in both methods in the future. Thus, the growing adoption of 3D technology by the surgeon is anticipated to drive the growth of the market.

In addition, the market is growing as a result of the rising prevalence of obesity and the demand for bariatric surgery. According to the World Health Organization in June 2021, there were 39 million under-five years old kids who were overweight or obese in 2020.Overweight and obesity, once thought to be a problem only in high-income nations are now becoming more prevalent in low- and middle-income nations as well, especially in urban areas. Moreover, World Obesity Atlas March 2022 published by the World Obesity Federation, predicts that by 2030, one billion people worldwide, including one in five women and one in seven men, will have obesity. As a result, the market for 3D laparoscopy imaging market is anticipated to grow over the projection period due to the rising prevalence of obesity and the increased need for the procedure.

In addition, a conventional laparoscopic camera consists of only a 2-Dimensional (2D) system and although there is an improvement in graphics from a high definition (HD) system, there is still a lack of depth and spatial perception. 3-Dimensional (3D) systems can potentially improve laparoscopic training by eliminating the need to overcome the loss of stereoscopic vision likely to affect market growth positively. For instance, in January 2020, Karl Storz SE & Co. KG launched a new 3D surgical imaging system with a modular camera platform. The new system allows for better visualization of microsurgical and open interventions in different surgical fields.

Thus, all aforementioned factors are anticipated to boost the market growth over the forecast period. However, the high costs associated with the products restrain the market growth.

3D Laparoscopy Imaging Market Trends

Bariatric Surgery is Expected to Hold Significant Market Share by Application Over the Forecast Period

Due to the increasing number of bariatric surgeries performed, the market will continue to grow. The application scope of 3D laparoscopy imaging systems is likely to expand in bariatric surgeries, as surgeons require a stereoscopic vision of anatomy for an accurate dissection prior to surgery.

According to the World Health Organization's report published in June 2021, One in five children and adolescents globally are overweight. Incidences of obesity have been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Furthermore, as per the study titled "Bariatric and Metabolic Surgery in India: Where Do We Stand?" published in the Indian Journal of Surgery in January 2022, a total of 833,687 bariatric procedures were performed around the world in 2020. in addition as per the same source, Over 1.9 billion adults worldwide are overweight, with 650 million being obese. Thus, the high burden of obesity and rising in the number of bariatric surgery performed across globe anticipated to drive the demand of 3D laparoscopy imaging thereby boost the segment growth.

Obesity is also associated with substantial increases in premature mortality, impaired quality of life, and substantial costs of healthcare. The major comorbidities include hypertension, Type-2 diabetes, dyslipidaemia, myocardial infarction, certain cancers, stroke, sleep apnea, and osteoarthritis. Most of the comorbidities are the leading causes of death too.

Thus, increase the safety of the bariatric surgical techniques, driving the growth of the segment in the market.

North America Dominates the Market and is expected to continue so Over the Forecast Period

North America dominates the 3D laparoscopic imaging market over the forecast period. This can be attributed to a growing preference for laparoscopic surgery over open surgery, as well as increased awareness of the advantages of minimally invasive procedures. Furthermore, product innovation competition among major players will have an impact on the market.

Furthermore, the market is being propelled forward by a growing demand for minimally invasive 3D laparoscopic equipment. Because of the less trauma they cause, minimally invasive surgical methods are becoming more popular. For example, in December 2020, Olympus reported that their VISERA ELITE II surgical imaging platform for minimally invasive surgery will now include 3D and infrared capabilities. The addition of a platform like this could aid hospitals and operation centers in increasing efficiency and lowering costs. Gynecology, general surgery, orthopedic surgery, endourology, and ENT are just a few of the applications for the product. Furthermore, health insurance companies in some countries pay for minimally invasive laparoscopic surgeries. According to the Medicare Benefits Schedule march 2022, up to 75% of laparoscopic procedures are now covered by Medicare (MBS). As a result of these considerations, patients' preferences for minimally invasive surgeries have increased.

Moreover, increasing prevalence of obesity in the region anticipated to boost the market. In September 2020, the Centers for Disease Control and Prevention (CDC) May 2022, the prevalence of obesity in the United States increased from 30.5 to 41.9%. The prevalence of severe obesity rose from 4.7 percent to 9.2%. Moreover, As per United States National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States.Thus, increasing prevalence of the obesity and rising in spending of its treatment anticipated to boost the market growth.

Launch of technological advanced productby the key market players expected to grow the market over the forecast period. In December 2020, Olympus Corporation released an upgraded version of its rigid 3D ENDOEYE video laparoscope, which allows surgeons greater control than conventional 3D laparoscopes. The upgrade provides true horizon orientation for surgeons.

Hence, the rising demand for 3D laparoscopic imaging for bariatric and urologic surgeries is expected to propel the market growth in the region.

3D Laparoscopy Imaging Market Competitor Analysis

The global 3D laparoscopy imaging market is moderately competitive and consists of a few major players. Companies like Olympus Corporation, Sometech, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, Fujifilm Healthcare, Medtronic, and Siemens Healthineers, among others, hold the substantial market share in the 3D laparoscopy imaging market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for and Advancements of 3D Imaging Technology
    • 4.2.2 Rise in Obesity and Increase in Demand for Bariatric Surgeries
    • 4.2.3 Rising Demand for Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Products
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Application
    • 5.1.1 Gynecological Surgery
    • 5.1.2 Bariatric Surgery
    • 5.1.3 Urological Surgery
    • 5.1.4 Other Applications
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Olympus Corporation
    • 6.1.2 Sometech Inc.
    • 6.1.3 Karl Storz SE & Co. KG
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Conmed Corporation
    • 6.1.6 Medtronic Plc
    • 6.1.7 Siemens Healthineers
    • 6.1.8 Stryker Corporation
    • 6.1.9 Johnson & Johnson Medical Devices
    • 6.1.10 Richard Wolf GmbH
    • 6.1.11 Xion Medical
    • 6.1.12 Pentax Medical
    • 6.1.13 Fujifilm Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS